Only about 27% of patients newly diagnosed with focal epilepsy are seizure-free on initial anti-seizure medications, new ...

An ongoing campaign to fund medical cannabis for the East Kilbride boy, who has rare drug resistant focal epilepsy, has ...

Biohaven Ltd.’s BHV-7000, a selective Kv7.2/7.3 potassium channel activator, is in phase II/III development for the treatment ...

The focal seizures initially occurred weekly and progressed to generalized tonic–clonic seizures. During the subsequent 15 years, the patient received treatment with various medications and ...

[MUSIC PLAYING] CICELY DOWDELL-SMITH: A focal onset seizure is a burst of abnormal electrical activity on one side or in one part of the brain that affects one side or one part of the body or ...

UC San Diego is among more than 100 locations nationwide participating in new clinical trials for a drug that shows promise ...

Epidiolex is showing positive results for treating TSC, adding to its success with addressing Dravat Syndrome and Lennox ...

generalized seizures and focal or partial seizures. Partial seizures, also called focal or localized seizures, are limited to one hemisphere of your brain. When a partial seizure happens ...

Epilepsy, a prevalent neurological disorder, arises from abnormal electrical activity in the brain, leading to seizures. These seizures manifest in various forms, impacting individuals differently.

Rapport Therapeutics (RAPP) announced it will present “novel findings” on the association between a seizure biomarker used in the company’s ...

Jefferies analyst Andrew Tsai has assigned their bullish stance on XENE stock, giving a Buy rating on December 5.Pick the best stocks and ...

(Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, today announced new compelling ...